Christopher C Dewey - Net Worth and Insider Trading

Christopher C Dewey Net Worth

The estimated net worth of Christopher C Dewey is at least $325,592 dollars as of 2024-11-13. Christopher C Dewey is the Director of Myos Rens Technology Inc and owns about 26,864 shares of Myos Rens Technology Inc (MYOS) stock worth over $325,592. Details can be seen in Christopher C Dewey's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher C Dewey has not made any transactions after 2020-03-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Christopher C Dewey

Christopher C Dewey Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christopher C Dewey owns 6 companies in total, including Myos Rens Technology Inc (MYOS) , National Holdings Corp (NHLD) , and MedAvail Holdings Inc (MDVLQ) among others .

Click here to see the complete history of Christopher C Dewey’s form 4 insider trades.

Insider Ownership Summary of Christopher C Dewey

Ticker	Comapny	Transaction Date	Type of Owner
MYOS	Myos Rens Technology Inc	2020-03-31	director
NHLD	National Holdings Corp	2010-10-05	director & Vice Chairman
MDVLQ	MedAvail Holdings Inc	2019-08-06	director
		2020-12-17	director & 10 percent owner & Chief Executive Officer
		2020-12-17	director & 10 percent owner & Chief Executive Officer
		2020-12-17	director & 10 percent owner & Chief Executive Officer

Christopher C Dewey Latest Holdings Summary

Christopher C Dewey currently owns a total of 1 stock. Christopher C Dewey owns 26,864 shares of Myos Rens Technology Inc (MYOS) as of March 5, 2020, with a value of $325,592.

Latest Holdings of Christopher C Dewey

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
MYOS	Myos Rens Technology Inc	2020-03-05	26,864	12.12	325,592

Holding Weightings of Christopher C Dewey

Christopher C Dewey Form 4 Trading Tracker

According to the SEC Form 4 filings, Christopher C Dewey has made a total of 1 transactions in Myos Rens Technology Inc (MYOS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Myos Rens Technology Inc is the acquisition of 6,887 shares on March 5, 2020, which cost Christopher C Dewey around $100,000.

Insider Trading History of Christopher C Dewey

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Christopher C Dewey Trading Performance

GuruFocus tracks the stock performance after each of Christopher C Dewey's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher C Dewey is -20.69%. GuruFocus also compares Christopher C Dewey's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher C Dewey within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Christopher C Dewey's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Christopher C Dewey

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	-16.38
Relative Return to S&P 500(%)	1.32

Christopher C Dewey Ownership Network

Ownership Network List of Christopher C Dewey

No Data

Ownership Network Relation of Christopher C Dewey

Christopher C Dewey Owned Company Details

What does Myos Rens Technology Inc do?

Who are the key executives at Myos Rens Technology Inc?

Christopher C Dewey is the director of Myos Rens Technology Inc. Other key executives at Myos Rens Technology Inc include director & Chief Executive Officer Joseph Mannello , 10 percent owner David J Matlin , and director & 10 percent owner Ren Ren .

Myos Rens Technology Inc (MYOS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Myos Rens Technology Inc (MYOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Myos Rens Technology Inc (MYOS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Myos Rens Technology Inc (MYOS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Myos Rens Technology Inc Insider Transactions

No Available Data

What does National Holdings Corp do?

Who are the key executives at National Holdings Corp?

Christopher C Dewey is the director & Vice Chairman of National Holdings Corp. Other key executives at National Holdings Corp include 10 percent owner Daniel Asher , President and CFO Glenn C. Worman , and Chief Operating Officer John C. Desena .

National Holdings Corp (NHLD) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of National Holdings Corp (NHLD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of National Holdings Corp (NHLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

National Holdings Corp (NHLD)'s detailed insider trading history can be found in Insider Trading Tracker table.

National Holdings Corp Insider Transactions

No Available Data

What does MedAvail Holdings Inc do?

Who are the key executives at MedAvail Holdings Inc?

Christopher C Dewey is the director of MedAvail Holdings Inc. Other key executives at MedAvail Holdings Inc include Chief Financial Officer Ramona Seabaugh , director & Chief Executive Officer Mark Edward Doerr , and director & 10 percent owner Redco Ii Master Fund, L.p. .

MedAvail Holdings Inc (MDVLQ) Insider Trades Summary

Over the past 18 months, Christopher C Dewey made no insider transaction in MedAvail Holdings Inc (MDVLQ). Other recent insider transactions involving MedAvail Holdings Inc (MDVLQ) include a net sale of 303 shares made by Ramona Seabaugh ,

In summary, during the past 3 months, insiders sold 0 shares of MedAvail Holdings Inc (MDVLQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 303 shares of MedAvail Holdings Inc (MDVLQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 303 shares.

MedAvail Holdings Inc (MDVLQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

MedAvail Holdings Inc Insider Transactions

No Available Data

What does MedTech Acquisition Corp do?

Who are the key executives at MedTech Acquisition Corp?

Christopher C Dewey is the director & 10 percent owner & Chief Executive Officer of MedTech Acquisition Corp. Other key executives at MedTech Acquisition Corp include President & Therapeutics Jodi Devlin , 10 percent owner Equity Ab Frankenius , and director & 10 percent owner Mats Wahlstrom .

MedTech Acquisition Corp (MTAC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of MedTech Acquisition Corp (MTAC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MedTech Acquisition Corp (MTAC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

MedTech Acquisition Corp (MTAC)'s detailed insider trading history can be found in Insider Trading Tracker table.

MedTech Acquisition Corp Insider Transactions

No Available Data

What does MedTech Acquisition Corp do?

Who are the key executives at MedTech Acquisition Corp?

Christopher C Dewey is the director & 10 percent owner & Chief Executive Officer of MedTech Acquisition Corp. Other key executives at MedTech Acquisition Corp include 10 percent owner Magnetar Financial Llc , 10 percent owner Magnetar Capital Partners Lp , and 10 percent owner Supernova Management Llc .

MedTech Acquisition Corp (MTACU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of MedTech Acquisition Corp (MTACU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MedTech Acquisition Corp (MTACU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

MedTech Acquisition Corp (MTACU)'s detailed insider trading history can be found in Insider Trading Tracker table.

MedTech Acquisition Corp Insider Transactions

No Available Data

What does TriSalus Life Sciences Inc do?

Who are the key executives at TriSalus Life Sciences Inc?

Christopher C Dewey is the director & 10 percent owner & Chief Executive Officer of TriSalus Life Sciences Inc. Other key executives at TriSalus Life Sciences Inc include director & CEO and President Mary T Szela , President & Therapeutics Jodi Devlin , and 10 percent owner Equity Ab Frankenius .

TriSalus Life Sciences Inc (TLSI) Insider Trades Summary

Over the past 18 months, Christopher C Dewey made no insider transaction in TriSalus Life Sciences Inc (TLSI). Other recent insider transactions involving TriSalus Life Sciences Inc (TLSI) include a net purchase of 19,815 shares made by Mary T Szela , and a net sale of 9 shares made by George Kelly Martin .

In summary, during the past 3 months, insiders sold 9 shares of TriSalus Life Sciences Inc (TLSI) in total and bought 19,815 shares, with a net purchase of 19,806 shares. During the past 18 months, 9 shares of TriSalus Life Sciences Inc (TLSI) were sold and 19,815 shares were bought by its insiders, resulting in a net purchase of 19,806 shares.

TriSalus Life Sciences Inc (TLSI)'s detailed insider trading history can be found in Insider Trading Tracker table.

TriSalus Life Sciences Inc Insider Transactions

No Available Data

Christopher C Dewey Mailing Address

Above is the net worth, insider trading, and ownership report for Christopher C Dewey. You might contact Christopher C Dewey via mailing address: 120 Broadway, 27th Floor, New York Ny 10271.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.